Atom | NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Funder: National Institutes of Health

Funding Amounts: UG3 phase: <$400,000 direct costs (1 year); UH3 phase: no set limit, up to 5 years; total project period up to 6 years. Budgets over $500,000/year require pre-approval.

Summary: Supports planning and implementation of clinical trials for drugs, biologics, devices, or procedures addressing dental, oral, or craniofacial conditions through a phased UG3/UH3 cooperative agreement with NIDCR.

Key Information: Only applications proposing clinical trials are accepted; initial UG3 funding does not guarantee UH3 support; limited submission—see eligibility details.

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Sign in to see full grant listing